Shigeo Masuda, Shigeru Miyagawa, Satsuki Fukushima, Nagako Sougawa, Kaori Okimoto, Chika Tada, Atsuhiro Saito, Yoshiki Sawa. Eliminating residual iPS cells for safety in clinical application[J]. Protein&Cell, 2015, 6(7): 469-471. doi: 10.1007/s13238-015-0170-4
Citation:
|
Shigeo Masuda, Shigeru Miyagawa, Satsuki Fukushima, Nagako Sougawa, Kaori Okimoto, Chika Tada, Atsuhiro Saito, Yoshiki Sawa. Eliminating residual iPS cells for safety in clinical application[J]. Protein&Cell, 2015, 6(7): 469-471. doi: 10.1007/s13238-015-0170-4
|
Shigeo Masuda, Shigeru Miyagawa, Satsuki Fukushima, Nagako Sougawa, Kaori Okimoto, Chika Tada, Atsuhiro Saito, Yoshiki Sawa. Eliminating residual iPS cells for safety in clinical application[J]. Protein&Cell, 2015, 6(7): 469-471. doi: 10.1007/s13238-015-0170-4
Citation:
|
Shigeo Masuda, Shigeru Miyagawa, Satsuki Fukushima, Nagako Sougawa, Kaori Okimoto, Chika Tada, Atsuhiro Saito, Yoshiki Sawa. Eliminating residual iPS cells for safety in clinical application[J]. Protein&Cell, 2015, 6(7): 469-471. doi: 10.1007/s13238-015-0170-4
|